Interestingly, IDH1 action relies on the conversion of isocitrate to alfa-ketoglutarate; in case of IDH mutations, alfa-ketoglutarate is transformed by IDH1 into 2-hydroxyglutarate (2-HG), which plays a role in tumor progression [101,102]. Here, IDH2 is linked to neoplasm.